| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $275,405 ) |
| 2023 | 2023 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 26 | NIH | 8/25/2023 | $275,405 |
|
| Issue Date FY: 2022 ( Subtotal = $272,651 ) |
| 2022 | 2022 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 25 | NIH | 8/31/2022 | $272,651 |
|
| Issue Date FY: 2021 ( Subtotal = $275,405 ) |
| 2021 | 2021 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 001 | 24 | NIH | 8/30/2021 | $275,405 |
| 2021 | 2020 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 23 | NIH | 8/4/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $269,940 ) |
| 2020 | 2020 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | K1Y 4E9 | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 23 | NIH | 3/17/2020 | $269,940 |
|
| Issue Date FY: 2019 ( Subtotal = $296,935 ) |
| 2019 | 2019 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | K1Y 4E9 | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 001 | 22 | NIH | 4/25/2019 | $269,940 |
| 2019 | 2018 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | K1Y 4E9 | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 21 | NIH | 4/9/2019 | $26,995 |
|
| Issue Date FY: 2018 ( Subtotal = $242,945 ) |
| 2018 | 2018 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | K1Y 4E9 | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 21 | NIH | 3/22/2018 | $242,945 |
|
| Issue Date FY: 2017 ( Subtotal = $269,940 ) |
| 2017 | 2017 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | K1Y 4E9 | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 001 | 20 | NIH | 6/14/2017 | $26,995 |
| 2017 | 2017 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | K1Y 4E9 | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 20 | NIH | 5/5/2017 | $242,945 |
| 2017 | 2015 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 725 PARKDALE AVE | OTTAWA | ON | K1Y 4E9 | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 000 | 11 | NIH | 2/2/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $269,940 ) |
| 2016 | 2016 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 19 | NIH | 3/4/2016 | $269,940 |
| 2016 | 2015 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 000 | 11 | NIH | 3/1/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $281,194 ) |
| 2015 | 2015 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 000 | 11 | NIH | 12/25/2014 | $256,929 |
| 2015 | 2015 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 001 | 11 | NIH | 4/3/2015 | $24,265 |
|
| Issue Date FY: 2014 ( Subtotal = $498,847 ) |
| 2014 | 2014 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 002 | 18 | NIH | 7/10/2014 | $219,081 |
| 2014 | 2014 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 000 | 10 | NIH | 1/24/2014 | $256,929 |
| 2014 | 2014 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 001 | 10 | NIH | 3/26/2014 | $22,837 |
| 2014 | 2013 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 001 | 17 | NIH | 12/19/2013 | $214,457 |
| 2014 | 2013 | OTTAWA HOSPITAL RESEARCH INSTITUTE | 1053 CARLING AVENUE | OTTAWA | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 17 | NIH | 11/20/2013 | -$214,457 |
|
| Issue Date FY: 2013 ( Subtotal = $486,230 ) |
| 2013 | 2013 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 17 | NIH | 6/3/2013 | $214,457 |
| 2013 | 2013 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 001 | 9 | NIH | 6/24/2013 | $14,844 |
| 2013 | 2013 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 002 | 17 | NIH | 12/19/2013 | $214,457 |
| 2013 | 2013 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 000 | 9 | NIH | 12/14/2012 | $256,929 |
| 2013 | 2013 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 001 | 17 | NIH | 11/20/2013 | -$214,457 |
|
| Issue Date FY: 2012 ( Subtotal = $517,135 ) |
| 2012 | 2012 | THE OTTAWA HOSPITAL RESEARCH INSTITUTE, UNIV OF OTTAWA | 725 PARKDALE AVENUE | OTTAWA | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 16 | NIH | 5/16/2012 | $231,659 |
| 2012 | 2012 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 000 | 8 | NIH | 2/9/2012 | $285,476 |
|
| Issue Date FY: 2011 ( Subtotal = $535,743 ) |
| 2011 | 2011 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 001 | 7 | NIH | 6/30/2011 | $28,836 |
| 2011 | 2011 | THE OTTAWA HOSPITAL RESEARCH INSTITUTE, UNIV OF OTTAWA | 725 PARKDALE AVENUE | OTTAWA | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 001 | 15 | NIH | 6/24/2011 | $15,742 |
| 2011 | 2011 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 000 | 7 | NIH | 1/21/2011 | $259,524 |
| 2011 | 2011 | THE OTTAWA HOSPITAL RESEARCH INSTITUTE, UNIV OF OTTAWA | 725 PARKDALE AVENUE | OTTAWA | | | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 15 | NIH | 4/26/2011 | $231,641 |
|
| Issue Date FY: 2010 ( Subtotal = $473,378 ) |
| 2010 | 2010 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | OTTAWA | | - | | CAN | R01AR044031 | Genetic Regulation of Skeletal Muscle Repair | 000 | 14 | NIH | 4/29/2010 | $257,378 |
| 2010 | 2010 | LOEB HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | - | | CAN | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 001 | 6 | NIH | 2/26/2010 | $216,000 |
| 2010 | 2008 | OTTAWA HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | OTTAWA | | | | | U01HL077885 | Resuscitation Outcomes Consortium (ROC) Regional Clinical Center-OTTAWA-OPALS-BCR | 000 | 5 | NIH | 2/25/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $267,099 ) (Continued on the next page) |
| 2009 | 2009 | LOEB HEALTH RESEARCH INSTITUTE | 725 PARKDALE AVENUE | Ottawa | | - | | CAN | F33CA144208 | ROLE AND REGULATION OF GNRH AND RECEPTORS IN CISPLATIN RESISTANT OVARIAN CANCER | 000 | 1 | NIH | 9/29/2009 | $54,820 |
|